バイエルのインスタグラム(bayerofficial) - 1月7日 18時16分

Bayer has signed a #collaboration and services agreement with CureVac, a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA).

Under the terms of the agreement, Bayer will support the further development, supply and key territory operations of CureVac´s #COVID19 vaccine candidate CVnCoV.

To this end, Bayer will contribute its expertise and established infrastructure in areas such as clinical operations, regulatory affairs, pharmacovigilance, medical information, supply chain performance as well as support in selected countries.

#TeamBayer
#strongertogether #vaccine #curevac #covid_19 #corona #coronavirus

[BIHAKUEN]UVシールド(UVShield) 更年期に悩んだら

>> 飲む日焼け止め！「UVシールド」を購入する